Detalles de la búsqueda
1.
Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors.
Med Sci Monit
; 23: 1636-1644, 2017 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28376075
2.
Discovery of mass spectral peak markers and protein biomarkers in fish muscle exudates for rapid and precise recognition of fish species via magnetic beads (MBs) and mass spectrometry.
Food Chem X
; 22: 101509, 2024 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38883916
3.
Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy.
Future Med Chem
; 16(4): 369-388, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38288571
4.
Amide proton transfer-weighted and arterial spin labeling imaging may improve differentiation between high-grade glioma recurrence and radiation-induced brain injury.
Heliyon
; 10(11): e32699, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38961946
5.
Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer.
J Med Chem
; 66(23): 16235-16256, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38033250
6.
Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer.
J Med Chem
; 66(6): 4215-4230, 2023 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36800260
7.
Discovery of Potent and Wild-Type-Sparing Fourth-Generation EGFR Inhibitors for Treatment of Osimertinib-Resistance NSCLC.
J Med Chem
; 66(10): 6849-6868, 2023 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37141440
8.
PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis.
Front Immunol
; 13: 805311, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35154122
9.
Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma.
Cancers (Basel)
; 14(15)2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35892886
10.
Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma.
Eur J Med Chem
; 228: 114024, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875521
11.
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
Nat Commun
; 13(1): 2903, 2022 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35614066
12.
Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia.
J Med Chem
; 65(1): 857-875, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958208
13.
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer.
J Med Chem
; 65(22): 15102-15122, 2022 11 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36350721
14.
Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia.
Eur J Med Chem
; 221: 113522, 2021 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33984804
15.
ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Pathol Oncol Res
; 24(3): 663-670, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28828637
16.
Performance of pfHRP2 versus pLDH antigen rapid diagnostic tests for the detection of Plasmodium falciparum: a systematic review and meta-analysis.
Arch Med Sci
; 13(3): 541-549, 2017 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28507567
17.
The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.
Biomed Res Int
; 2017: 5358615, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28540298
18.
Corrigendum to "Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia" [Eur. J. Med. Chem. 221 (2021) 113522].
Eur J Med Chem
; 228: 114041, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34902733
19.
Correction to "Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia".
J Med Chem
; 65(9): 6969-6970, 2022 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486536
Resultados
1 -
19
de 19
1
Próxima >
>>